|
Post by happyjawa on Jan 8, 2015 0:48:48 GMT
It's fixed Yep. OTC is having some weird glitches the past few days. North Korea? Kim Jong Un is apparently the MM that has been keeping the price of ONCS down for so long.
|
|
|
Post by RLC on Jan 8, 2015 1:25:29 GMT
It's fixed Yep. OTC is having some weird glitches the past few days. North Korea? Kim is at it again. What is really strange about this is that the sales show up as if they actually occurred (see attached). Maybe I'll throw a few limit orders up in hopes that I get lucky.
|
|
|
Post by sidewinder on Jan 9, 2015 15:20:50 GMT
Took a small position today. Thanks guys...now lets hope for good things!!!
|
|
|
Post by JHam on Jan 9, 2015 15:31:24 GMT
Took a small position today. Thanks guys...now lets hope for good things!!! Welcome to the "party". This one may take some patients so I hope you are in for a quick flip Either way, good buy at today's low price, in my opinion. Good luck!
|
|
|
Post by RLC on Jan 12, 2015 18:24:41 GMT
A new blog was finally posted on their website: oncosec.com/introspective-immunotherapy/ It isn't very revealing as it's in regards to their event scheduled for tomorrow, but still nice to see some activity there. I think the last blog posted on their webpage was mid-2014. Let's hope they make a big splash tomorrow! Surely Dr. Pierce will make believers out of some.
|
|
|
Post by JHam on Jan 12, 2015 22:56:57 GMT
A new blog was finally posted on their website: oncosec.com/introspective-immunotherapy/ It isn't very revealing as it's in regards to their event scheduled for tomorrow, but still nice to see some activity there. I think the last blog posted on their webpage was mid-2014. Let's hope they make a big splash tomorrow! Surely Dr. Pierce will make believers out of some. Nice! Thanks for posting. Full disclosure here. I took some off the top today and put it into ATHX and NRIFF. I haven't lost any faith in ONCS, but simple think that pps impacting near term catalysts will happen for those two companies before they happen with ONCS. Besides I still own more than enough shares of ONCS.
|
|
|
Post by avtech on Jan 14, 2015 21:55:19 GMT
Decided to nibble on this one today. Fully expect to double in a year. For that, I will hold. Thanks for sharing. I am intrigued by the science.
|
|
|
Post by sidewinder on Jan 14, 2015 23:25:33 GMT
Woot Woot...I'm up 10 dollars so far. In all seriousness, the more I dig into this one the more I like it!!
|
|
|
Post by Yelk on Jan 29, 2015 2:56:58 GMT
As of today getting near the $.36 all time low PPS (since 2013). I've been following the threads for this company for a while but haven't done much DD. I might open a position tomorrow literally because the PPS is so attractive and add after more research.
|
|
|
Post by RLC on Jan 29, 2015 3:38:11 GMT
The chart isn't looking too good here right now. Without some news to help bring some new capital in (which isn't likely in the immediate future IMO), I could easily see this sitting in the mid $.30's for quite some time. Because of this, I sold off 25% of my position at $.395 yesterday (13% realized loss). I'm still very excited about the potential here. It seems incredibly likely that the combo trial with Merck's Keytruda will show Merck what they're wanting to see. If/When this occurs, I'll likely double down on my current position and trade the newly purchased shares in 5 equal blocks each time it goes up 20 cents (maybe/hopefully we're talking dollars by then if they get their capital structure in order and get listed on a reputable exchange). The cult following this company has seems to make it a traders paradise (like ACTC/OCAT has been and will continue to be). I need to make sure to take advantage of the volatile swings this time!
|
|
|
Post by Yelk on Jan 29, 2015 5:12:28 GMT
Yeah you have a point could get lucky and get in maybe high 20's I'm just so sick of getting in after the initial 70% rides and having more risk. Almost seems less risky too get in early and take a hit and take the full ride. Obviously depends on what stock, if it goes down below $.36 I probably will go in small -we'll see. Like you said I don't really have cash to sit dormant in all these stocks so I agree may be a waste.
|
|
|
Post by happyjawa on Jan 29, 2015 6:37:39 GMT
This stock is killing me. If you want in on this ride, welcome to the party. I invested in OCAT for three years. This company is child's play by comparison.
|
|
|
Post by JHam on Jan 29, 2015 7:54:40 GMT
The chart isn't looking too good here right now. Without some news to help bring some new capital in (which isn't likely in the immediate future IMO), I could easily see this sitting in the mid $.30's for quite some time. Because of this, I sold off 25% of my position at $.395 yesterday (13% realized loss). I'm still very excited about the potential here. It seems incredibly likely that the combo trial with Merck's Keytruda will show Merck what they're wanting to see. If/When this occurs, I'll likely double down on my current position and trade the newly purchased shares in 5 equal blocks each time it goes up 20 cents (maybe/hopefully we're talking dollars by then if they get their capital structure in order and get listed on a reputable exchange). The cult following this company has seems to make it a traders paradise (like ACTC/OCAT has been and will continue to be). I need to make sure to take advantage of the volatile swings this time! I hear ya. Still frustrated for not selling some at $.65 back in December. I think the combo trial will show very good results. I also think that it won't take too long to have data since according to Furbush who went to the symposium the other day, it is only going to be a 10 patient study. In the past I would probably just have held on added more, as I do think ONCS is onto something. There are just too many other opportunities right now that I don't want to miss out on instead of sitting and waiting with ONCS. I'll likely start buying after I trade some of my other stocks and as we get closer to May or if it drops into the low $.30s. The current prices are a bargain. I can't imagine the pps going into the $.20s, but you never know. That would really be a steal in my opinion. Dr. Pierce is apparently going to be presenting unpublished data at a conference in May. Not sure what it will be. Seems to soon to be P2b interim data or H&N.
|
|
|
Post by RLC on Jan 29, 2015 14:12:41 GMT
The chart isn't looking too good here right now. Without some news to help bring some new capital in (which isn't likely in the immediate future IMO), I could easily see this sitting in the mid $.30's for quite some time. Because of this, I sold off 25% of my position at $.395 yesterday (13% realized loss). I'm still very excited about the potential here. It seems incredibly likely that the combo trial with Merck's Keytruda will show Merck what they're wanting to see. If/When this occurs, I'll likely double down on my current position and trade the newly purchased shares in 5 equal blocks each time it goes up 20 cents (maybe/hopefully we're talking dollars by then if they get their capital structure in order and get listed on a reputable exchange). The cult following this company has seems to make it a traders paradise (like ACTC/OCAT has been and will continue to be). I need to make sure to take advantage of the volatile swings this time! I hear ya. Still frustrated for not selling some at $.65 back in December. I think the combo trial will show very good results. I also think that it won't take too long to have data since according to Furbush who went to the symposium the other day, it is only going to be a 10 patient study. In the past I would probably just have held on added more, as I do think ONCS is onto something. There are just too many other opportunities right now that I don't want to miss out on instead of sitting and waiting with ONCS. I'll likely start buying after I trade some of my other stocks and as we get closer to May or if it drops into the low $.30s. The current prices are a bargain. I can't imagine the pps going into the $.20s, but you never know. That would really be a steal in my opinion. Dr. Pierce is apparently going to be presenting unpublished data at a conference in May. Not sure what it will be. Seems to soon to be P2b interim data or H&N. I agree there are places in which capital has a much greater chance for near term appreciation than ONCS. However, it wouldn't surprise me at all to see this company get some institutional investment at any given time (obviously being listed on a national exchange would help in this regard). Immunology (specifically in the oncology space) is on fire.... More like exploding at the moment. The smart money seems to be placing their bets on the product (or combination of products) that is most likely to succeed in the wide-spread effective treatment of cancers. Who knows what bit of data will push them to place a bet on ONCS. I do feel confident that we'll be presented the opportunity to turn a profit here eventually. Still holding a large position.
|
|
|
Post by RLC on Jan 29, 2015 17:26:33 GMT
Not a pretty picture here today. Looks awfully close to the 52-week low with no sight of near-term support IMO. I don't think any "fluff" news can save us either. We need the data that the market is waiting for, and unfortunately the market is smart enough to realize that any meaningful data is down the road quite a ways.
I'm not even going to look at the Google board today. I'm sure it's filled with panic and ruthless illogical attacks on people that contributed lots of time/research in an attempt to assist others.
|
|
|
Post by RLC on Jan 29, 2015 17:49:17 GMT
Scratch that... support appearing to be relatively strong at $.35 (there are some massive buy orders in right now @ $.35), but how long this will hold is anybody's guess...
|
|
|
Post by Yelk on Jan 29, 2015 17:51:43 GMT
I decided to hold off. If it goes to $.29-$.32 I will be forced in but right now I am all tied up in other companies...
|
|
|
Post by JHam on Jan 29, 2015 17:54:12 GMT
I decided to hold off. If it goes to $.29-$.32 I will be forced in but right now I am all tied up in other companies... Some heavy volume today with this sell off.
|
|
|
Post by Yelk on Jan 29, 2015 18:05:05 GMT
Wow down 9%, any reason aside from realization of no near term major catalyst? Tempted to buy even more now but will hold with original decision to wait.
|
|
|
Post by happyjawa on Jan 29, 2015 19:17:13 GMT
I decided to hold off. If it goes to $.29-$.32 I will be forced in but right now I am all tied up in other companies... Some heavy volume today with this sell off. If the Google board is any indication, it looks like all the weaker retail buyers are dumping. Maybe I'll be able to read some posts without having to filter through 40 posts of people complaining and calling each other names from here on out.
|
|